Welltower Inc
Q4 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: −3.31%.
Did WELL Beat Earnings? Q4 2025 Results
Welltower closed out the fourth quarter of 2025 with a transformative flourish, reporting earnings per share of $0.14 on revenue of $3.18 billion while delivering normalized FFO of $1.45 per share — a 28.3% year-over-year gain that underscored the operational momentum building across its seniors housing portfolio. The single most compelling driver was the Seniors Housing Operating segment, where same-store NOI surged 20.4% year-over-year as average occupancy climbed 400 basis points to 89.5% and RevPOR grew 4.7%, pushing total blended SSNOI growth to 15.0%. The quarter also featured $13.90 billion in pro rata gross investments, anchored by the landmark Barchester and HC-One acquisitions in the U.K., which added over 400 senior communities to the company's international footprint. Meanwhile, credit upgrades from both S&P and Moody's and net debt to Adjusted EBITDA falling to 3.03x signaled a materially stronger balance sheet. With <a href="https://247wallst.com/investing/2026/02/23/real-estate-stocks-rise-realty-income-o-simon-property-spg-lead-last-weeks-winners/">real estate stocks broadly gaining</a> on stabilizing rates, Welltower added to the sector's momentum by guiding 2026 normalized FFO to $6.09–$6.25 per diluted share, with SHO same-store NOI growth of 15.0% to 21.0%.
- SHO same store NOI growth of 20.4% year-over-year
- 400 basis points of average occupancy growth to 89.5% in SHO same store portfolio
- 4.7% RevPOR growth in SHO portfolio
- 270 bps same store NOI margin expansion year-over-year
- Total portfolio SSNOI growth of 15.0%
- Normalized FFO per share growth of 28.3% year-over-year
Forward Guidance & Outlook
For 2026, Welltower expects net income attributable to common stockholders of $3.11 to $3.27 per diluted share and normalized FFO of $6.09 to $6.25 per diluted share. Same Store NOI growth is expected at 11.25% to 15.75% blended, comprised of Seniors Housing Operating at 15.0% to 21.0%, Seniors Housing Triple-net at 3.0% to 4.0%, Outpatient Medical at 2.0% to 3.0%, and Long-Term/Post-Acute Care at 2.0% to 3.0%. G&A expenses are anticipated at $260 million to $270 million including approximately $60 million in stock-based compensation. The company expects $3.5 billion of pro rata dispositions at a blended yield of 6.8% and $370 million of development funding in 2026. Guidance includes only announced or closed acquisitions to date.
WELL YoY Financials
WELL Revenue by Segment
WELL Revenue by Geography
Figures from SEC filings and company reports. Not investment advice.